---
figid: PMC2873720__f1-PTJ35_4p219
figtitle: Site of action for tyrosine kinase inhibitors (TKI) and monoclonal antibodies
  (mAb) in the EGFR signaling pathway
organisms:
- NA
pmcid: PMC2873720
filename: f1-PTJ35_4p219.jpg
figlink: /pmc/articles/PMC2873720/figure/f1-ptj35_4p219/
number: F1
caption: Site of action for tyrosine kinase inhibitors (TKI) and monoclonal antibodies
  (mAb) in the EGFR signaling pathway. ECM = extracellular matrix; EGFR = epidermal
  growth factor receptor. (From Harari PM, Huang SM. Semin Radiat Oncol 2002; 12[3
  Suppl 2]:2126. Reproduced with permission of Elsevier.)
papertitle: The Escalating Role of Epidermal Growth Factor Receptor Inhibitors in
  Cancer Management.
reftext: Dwight D. Kloth, et al. P T. 2010 Apr;35(4):219-229.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9119906
figid_alias: PMC2873720__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC2873720__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2873720__f1-PTJ35_4p219.html
  '@type': Dataset
  description: Site of action for tyrosine kinase inhibitors (TKI) and monoclonal
    antibodies (mAb) in the EGFR signaling pathway. ECM = extracellular matrix; EGFR
    = epidermal growth factor receptor. (From Harari PM, Huang SM. Semin Radiat Oncol
    2002; 12[3 Suppl 2]:2126. Reproduced with permission of Elsevier.)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mab
  - Egfr
  - CycE
  - cyc
  - LanB2
  - anon-70Db
  - anon-70Dc
  - tub
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - sm
  - tyrosine
---
